GlassScriptPhysician profile
Richard J Davison
NPI 1629147137
$1,890.04
in general payments reported to CMS, 2019-2025
9 companies · $663 in 2025
The $663 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $492 · 2021: $79.07 · 2022: $208 · 2023: $141 · 2024: $110 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $500 · Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $500.00 |
| Food and Beverage | $413.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $738.13 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $721.53 | 2019-2025 | Precision 1, Total30, Precision7 |
| Carl Zeiss Meditec USA, INC. | $155.52 | 2022 | |
| Abbvie INC. | $105.63 | 2025 | |
| Johnson & Johnson Vision Care, INC. | $59.76 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $40.63 | 2019-2020 | |
| Eyevance Pharmaceuticals LLC | $32.38 | 2019 | |
| Allergan, INC. | $23.47 | 2021 | |
| Abb Con-Cise Optical Group LLC | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Davison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.